Platelet CD40 contributes to enhanced monocyte chemoattractant protein 1 levels in patients with resistant hypertension.

Christian Stumpf; Dorette Raaz; Lutz Klinghammer; Markus Schneider; Roland E Schmieder; Christoph D Garlichs; Stephan Achenbach

doi:10.1111/eci.12635

Platelet CD40 contributes to enhanced monocyte chemoattractant protein 1 levels in patients with resistant hypertension.

Christian Stumpf, Dorette Raaz, Lutz Klinghammer, Markus Schneider, Roland E Schmieder, Christoph D Garlichs, Stephan Achenbach

Department of Internal Medicine IV, Division of Nephrology and Hypertensiology

Research output: Contribution to journal › Original Article › peer-review

9 Citations (Web of Science)

Original language	English
Pages (from-to)	564-571
Journal	EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
Volume	46
Issue number	6
DOIs	https://doi.org/10.1111/eci.12635
Publication status	Published - 2016

Keywords

TARGET ORGAN DAMAGE
INFLAMMATORY MARKERS
ENDOTHELIAL-CELLS
HEART-DISEASE
ATHEROSCLEROSIS
LIGAND
HEALTH
RISK
MACROPHAGES
ACTIVATION

Access to Document

10.1111/eci.12635

Cite this

Stumpf, C., Raaz, D., Klinghammer, L., Schneider, M., Schmieder, R. E., Garlichs, C. D., & Achenbach, S. (2016). Platelet CD40 contributes to enhanced monocyte chemoattractant protein 1 levels in patients with resistant hypertension. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , 46(6), 564-571. https://doi.org/10.1111/eci.12635

Stumpf, Christian ; Raaz, Dorette ; Klinghammer, Lutz et al. / Platelet CD40 contributes to enhanced monocyte chemoattractant protein 1 levels in patients with resistant hypertension. In: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 2016 ; Vol. 46, No. 6. pp. 564-571.

@article{845802a225164008b6105ce6dee6368f,

title = "Platelet CD40 contributes to enhanced monocyte chemoattractant protein 1 levels in patients with resistant hypertension.",

keywords = "TARGET ORGAN DAMAGE, INFLAMMATORY MARKERS, ENDOTHELIAL-CELLS, HEART-DISEASE, ATHEROSCLEROSIS, LIGAND, HEALTH, RISK, MACROPHAGES, ACTIVATION",

author = "Christian Stumpf and Dorette Raaz and Lutz Klinghammer and Markus Schneider and Schmieder, {Roland E} and Garlichs, {Christoph D} and Stephan Achenbach",

year = "2016",

doi = "10.1111/eci.12635",

language = "English",

volume = "46",

pages = "564--571",

journal = "EUROPEAN JOURNAL OF CLINICAL INVESTIGATION ",

issn = "0014-2972",

publisher = "Wiley Verlag ",

number = "6",

}

Stumpf, C, Raaz, D, Klinghammer, L, Schneider, M, Schmieder, RE, Garlichs, CD & Achenbach, S 2016, 'Platelet CD40 contributes to enhanced monocyte chemoattractant protein 1 levels in patients with resistant hypertension.', EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , vol. 46, no. 6, pp. 564-571. https://doi.org/10.1111/eci.12635

Platelet CD40 contributes to enhanced monocyte chemoattractant protein 1 levels in patients with resistant hypertension. / Stumpf, Christian; Raaz, Dorette; Klinghammer, Lutz et al.
In: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , Vol. 46, No. 6, 2016, p. 564-571.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Platelet CD40 contributes to enhanced monocyte chemoattractant protein 1 levels in patients with resistant hypertension.

AU - Stumpf, Christian

AU - Raaz, Dorette

AU - Klinghammer, Lutz

AU - Schneider, Markus

AU - Schmieder, Roland E

AU - Garlichs, Christoph D

AU - Achenbach, Stephan

PY - 2016

Y1 - 2016

KW - TARGET ORGAN DAMAGE

KW - INFLAMMATORY MARKERS

KW - ENDOTHELIAL-CELLS

KW - HEART-DISEASE

KW - ATHEROSCLEROSIS

KW - LIGAND

KW - HEALTH

KW - RISK

KW - MACROPHAGES

KW - ACTIVATION

U2 - 10.1111/eci.12635

DO - 10.1111/eci.12635

M3 - Original Article

C2 - 27090943

SN - 0014-2972

VL - 46

SP - 564

EP - 571

JO - EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

JF - EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

IS - 6

ER -

Stumpf C, Raaz D, Klinghammer L, Schneider M, Schmieder RE, Garlichs CD et al. Platelet CD40 contributes to enhanced monocyte chemoattractant protein 1 levels in patients with resistant hypertension. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION . 2016;46(6):564-571. doi: 10.1111/eci.12635